Loading clinical trials...
Loading clinical trials...
An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
The purpose of this trial is to give a shorter course (5 ½-6 weeks) of proton radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of proton radiation, without decreasing the chance of killing prostate cancer cells.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States
Start Date
September 1, 2011
Primary Completion Date
August 1, 2025
Completion Date
August 1, 2025
Last Updated
August 29, 2025
361
ACTUAL participants
70 Gy/CGE
RADIATION
72.5 Gy/CGE
RADIATION
Lead Sponsor
University of Florida
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions